Back to Results
First PageMeta Content
Pharmacy / Pharmaceuticals policy / Health / Clinical research / Essential medicines / Good Clinical Practice / Good manufacturing practice / Neglected diseases / Clinical trial / Pharmaceutical sciences / Pharmaceutical industry / Pharmacology


Human Rights Guidelines for Pharmaceutical Companies in relation to Access to Medicines Preamble
Add to Reading List

Document Date: 2014-08-21 10:57:42

Open Document

File Size: 70,50 KB

Share Result on Facebook

City

Helsinki / /

Company

Public Private Partnerships / Other Business Enterprises / Transnational Corporations / /

Continent

Africa / /

Event

FDA Phase / /

IndustryTerm

clear management systems / biotechnology / responsive and accessible health systems / health services / pharmaceutical sector / human rights law / diagnostic tools / health systems / active pharmaceutical ingredients / pharmaceutical / related healthcare technologies / manufacturing capacity / /

MedicalCondition

African trypanosomiasis / communicable diseases / malaria / kala-azar / neglected diseases / river blindness / heart disease / schistosomiasis / leishmaniasis / diabetes / sickness / lymphatic filariasis / Chagas disease / poverty-related diseases / diseases / onchocerciasis / HIV/AIDS / dengue / leprosy / tuberculosis / /

Organization

World Health Organisation / civil society / Committee on Economic / Social and Cultural Rights / World Bank / United Nations / World Trade Organization / /

Position

Representative / Secretary General / /

Product

Medicinal Drug / /

PublishedMedium

Commentary / /

Region

East Asia / /

Technology

biopharmaceuticals / biotechnology / related healthcare technologies / /

SocialTag